Akerman M, Rydholm A, Persson B M
Acta Orthop Scand. 1985 Oct;56(5):407-12. doi: 10.3109/17453678508994359.
Since 1972, we have included fine-needle aspiration cytology in the pre-operative evaluation of soft tissue lesions referred to our Orthopedic Oncology Group. In 365 consecutive patients the cytodiagnosis was correctly malignant in 66/74 tumors and correctly benign in 260/271 lesions; cytology was non-diagnostic in four sarcomas and 16 benign lesions. The final pre-operative diagnosis should be based on all pre-operative data to minimize the effect of any misjudgement as regards cytodiagnosis; only two of the 19 false cytodiagnoses were of consequence for the patient. We conclude that aspiration cytology used in this way is a valuable adjunct to determine the further management of soft tissue tumors.
自1972年以来,我们将细针穿刺细胞学检查纳入了转至我们骨肿瘤学小组的软组织病变的术前评估中。在连续365例患者中,74个肿瘤中有66个的细胞诊断正确为恶性,271个病变中有260个的细胞诊断正确为良性;4例肉瘤和16例良性病变的细胞学检查未能得出诊断结果。最终的术前诊断应基于所有术前数据,以尽量减少细胞诊断方面任何误判的影响;19例假性细胞诊断中只有2例对患者有影响。我们得出结论,以这种方式使用的穿刺细胞学检查是确定软组织肿瘤进一步治疗方案的有价值辅助手段。